NOD-like Receptor (NLR) Inhibitors

NLRP3

NLRP1

NOD1

NOD2

NOD-like Receptor (NLR) Degraders, Inhibitors, Agonists, Antagonists & Activators

Product Name	NLRP3	NLRP1	NOD1	NOD2	Purity
Nigericin sodium salt	NLRP3				99.37%
MCC950 sodium	NLRP3				99.75%
MCC950	NLRP3				99.62%
Nigericin	NLRP3				99.37%
INF 195	NLRP3				99.55%
CY-09	NLRP3				98.01%
QS-21	NLRP3 inflammasome				99.67%
Muramyl dipeptide		NLRP1			≥98.0%
Trimethylamine N-oxide	NLRP3				≥98.0%
GSK717				NOD2	99.88%
NLRP3/AIM2-IN-3	NLRP3				98.00%
Dapansutrile	NLRP3				≥98.0%
Stavudine	NLRP3				99.87%
BMS-986299	NLRP3, EC₅₀: 1.28 μM				99.76%
Muscone	NLRP3				≥98.0%
Selnoflast	NLRP3				98.58%
NOD-IN-1			NOD1	NOD2	99.56%
Mifamurtide				NOD2	≥99.0%
Ruscogenin	NLRP3				99.59%
Licochalcone B	NLRP3				99.93%
Trimethylamine N-oxide dihydrate	NLRP3				≥98.0%
Arglabin	NLRP3				99.87%
CORM-3	NLRP3
JC2-11	NLRP3 inflammasome				98.02%
YQ128	NLRP3, IC₅₀: 0.30 μM				99.83%
NLRP3-IN-13	NLRP3				99.01%
4'-Methoxyresveratrol	NLRP3				99.48%
Britannin	NLRP3, IC₅₀: 3.630 μM				99.93%
Soyasaponin II	NLRP3 inflammasome				99.81%
Emlenoflast	NLRP3 inflammasome, IC₅₀: <100 nM				98.19%
(±)11(12)-EET	NLRP3 inflammasome				98.3%
Emlenoflast sodium	NLRP3 inflammasome, IC₅₀: <100 nM				98.76%
L6H21	NLRP3 inflammasome				99.46%
Mifamurtide sodium				NOD2	98.19%
Oxidized ATP trisodium salt	NLRP3 inflammasome				≥98.0%
NVP-DFV890	NLRP3				98.47%
NLRP3-IN-18	NLRP3, IC₅₀: ≤1.0 μM				98.06%
HMGB1-IN-1	NLRP3				99.37%
Moronic acid	NLRP3				98.6%
NP3-562	NLRP3, IC₅₀: 214 nM				98.16%
Articaine hydrochloride	NLRP3				99.38%
NLRP3-IN-11	NLRP3, IC₅₀: <0.3 μM				98.79%
BAL-0028	NLRP3, IC₅₀: 25 nM
NLRP3-IN-17	NLRP3 inflammasome, IC₅₀: 7 nM				99.23%
SLC3037	NLRP3				99.85%
JC-171	NLRP3				98.41%
INF4E	NLRP3				99.38%
NOD2 antagonist 1				NOD2, IC₅₀: 5.23 μM	99.57%
Mifamurtide TFA				NOD2	≥98.0%
NLRP3-IN-NBC6	NLRP3, IC₅₀: 574 nM				99.40%
NT-0249	NLRP3
NDT-30805	NLRP3 inflammasome NLRP3
TLR7 agonist 27				NOD2, EC₅₀: 6156 nM
NOD1-IN-1			NOD1, IC₅₀: 33 nM
NLRP3-IN-9	NLRP3
NLRP3-IN-38	NLRP3 inflammasome, EC₅₀: 23 nM
NOD1 antagonist-1			NOD1, IC₅₀: 9.18 μM	NOD2, IC₅₀: 20.8 μM
Articaine	NLRP3
NLRP3-IN-32	NLRP3 inflammasome
P2Y14R antagonist 1	NLRP3
AMS-17	NLRP3
NOD2 agonist 3				NOD2, EC₅₀: 111.45 nM
MC1	NLRP3, Kd: 19.3 nM
NOD1/2-IN-1			NOD1, IC₅₀: 18 nM	NOD2, IC₅₀: 170 nM
JT001	NLRP3
NLRP3-IN-4	NLRP3
NOD1/2 antagonist-1			NOD1, IC₅₀: 1.13 μM	NOD2, IC₅₀: 0.77 μM
NLRP3-IN-45	NLRP3 inflammasome
NLRP3-IN-15	NLRP3 inflammasome
JT001 sodium	NLRP3
NLRP3-IN-6	NLRP3 inflammasome
RC529-MDP				NOD2
NP3-146	NLRP3
NLRP3-IN-42	NLRP3, Kd: 1.15 μM
NLRP3-IN-16	NLRP3 inflammasome
MR2938	NLRP3
α-Glucosidase/NLRP3-IN-1	NLRP3
NLRP3-IN-55	NLRP3, IC₅₀: 0.34 μM NLRP3, Kd: 0.45 μM
NLRP3-IN-36	NLRP3, IC₅₀: ＜1 μM
NLRP3-IN-7	NLRP3 inflammasome
NLRP3-IN-14	NLRP3 inflammasome, Kd: 5.87 μM
NLRP3-IN-41	NLRP3
SBN-284	NLRP3 inflammasome, EC₅₀: 1 μM
NLRP3-IN-8	NLRP3 inflammasome NLRP3
MC-ND-18	NLRP3, DC₅₀: 125.5 nM
Stavudine sodium	NLRP3

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2024 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明

沪ICP备15051369号-4